Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Multivitamin Capsules And Tablets Market Expected to Be in 2029?

In the past few years, the dasatinib drugs market has seen considerable growth. It is projected to escalate from $1.45 billion in 2024 to $1.53 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. This upward trend in the historic period can be ascribed to a surge in the incidence of chronic myeloid leukemia (CML), advancement in targeted cancer therapies, progress in tyrosine kinase inhibitors (TKIS) research, increased funding in oncology research, and a growth in the number of clinical trials.

Over the next few years, the market size of dasatinib drugs is set to witness robust growth, reaching “$1.95 billion in 2029” projecting a compound annual growth rate (CAGR) of “6.3%“. The predicted growth during the forecast period is due to several reasons such as an increase in funding for oncology drug development, a surge in drug-resistant leukemia cases, wider access to generic versions of dasatinib, an intensified focus on reducing chemotherapy side effects, and rising consciousness and early detection of leukemia. In addition, major trends shaping the growth during the forecast period include the rise of personalized medicines, the application of companion diagnostics, the emergence of new formulations, breakthroughs in combined therapies, and the evolution of biosimilars.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19023&type=smp

What Are The Contributors To Demand In The Multivitamin Capsules And Tablets Market?

The market for multivitamin capsules and tablets is experiencing growth due to the ongoing rise in health awareness among individuals. Multivitamin capsules and tablets, rich in various vitamins found in natural food sources, are frequently recommended by medical professionals to address or prevent vitamin deficiencies resulting from inadequate diet, certain medical conditions, or during pregnancy. The uptick in demand for multivitamins also correlates with the elevated health anxieties arising from the COVID-19 pandemic. A report from the International Food Information Council, a US-based nonprofit consumer research organization, stated in May 2022, that there was a 52% increase in Americans maintaining diet and eating habits from 2021 to 2022. Therefore, the multivitamin capsules and tablets market is projected to be spurred by the increase in health awareness during the forecast period.

The dasatinib drugs market covered in this report is segmented –

1) By Product Type: Tablets, Oral Suspension, Other Products

2) By Indication: Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications

3) By End User: Hospitals, Specialty Clinics, Home Healthcare

Subsegments:

1) By Tablets: 20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets

2) By Oral Suspension: 20 mg Or 5 mL Oral Suspension, 40 mg Or 5 mL Oral Suspension

3) By Other Products: Injectable Formulations, Combination Therapies, Generic Dasatinib Products

What Future Market Trends Are Projected For The Multivitamin Capsules And Tablets Industry?

To broaden their market reach, provide affordable treatments, and improve patient access, many leading firms in the dasatinib drugs market are concentrating on the development of generic medicines. By offering more cost-effective options, generic dasatinib drugs enhance patient access to treatment and foster competition, while also decreasing healthcare expenses for the patients. For example, Apotex Corp., a Canadian pharmaceutical firm, in September 2024, introduced the first generic version of Sprycel dasatinib in the United States. This medicine is used to treat select types of leukemia in adults and children. This economical alternative enhances access to top-notch treatment choices and symbolizes a substantial move towards intensifying competition and reducing costs in the dasatinib market.

Who Are The Top-Ranked Companies In The Multivitamin Capsules And Tablets Market Today?

Major companies operating in the dasatinib drugs market are Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sandoz Group AG, Hetero Drugs Limited, Sun Pharmaceutical Industries Limited, MSN Laboratories Pvt. Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., Biocon Limited, Alkem Laboratories Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Mylan N.V., Manus Aktteva Biopharma LLP

https://www.thebusinessresearchcompany.com/report/dasatinib-drugs-global-market-report

How Is Multivitamin Capsules And Tablets Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the dasatinib drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dasatinib drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19023&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model